Physician profile
Brinder S Kanda
NPI 1306008974
$33,581.93
in general payments reported to CMS, 2019-2025
25 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,067 · 2020: $354 · 2021: $2,942 · 2022: $4,856 · 2023: $2,731 · 2024: $5,389 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $7,227 · Consulting Fee: $1,000 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,111.65 |
| Food and Beverage | $7,226.57 |
| Consulting Fee | $1,000.00 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,529.51 | 2023-2025 | Corevalve Evolut R, Micra, Ffrangio |
| Abbott Laboratories | $8,162.53 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $6,744.83 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Boston Scientific Corporation | $2,156.14 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Medtronic Vascular, INC. | $1,444.91 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.41 | 2023-2025 | Lifevest |
| Cardiva Medical, INC. | $237.29 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Materialise USA LLC | $234.26 | 2021-2022 | |
| Abiomed | $134.93 | 2021-2024 | Impella |
| Ge Healthcare | $111.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $81.44 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $64.55 | 2024-2025 | Assure Wcd |
| W. L. Gore & Associates, INC. | $44.08 | 2024 | Gore Cardioform Septal Occluder |
| Penumbra, INC. | $38.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.35 | 2024-2025 | Camzyos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.01 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $32.34 | 2024-2025 | Verquvo |
| Acist Medical Systems, INC. | $29.00 | 2025 | |
| Heartflow, INC. | $25.06 | 2025 | |
| Shockwave Medical, INC | $24.18 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Novo Nordisk INC | $24.12 | 2024 | Rybelsus, Ozempic |
| Biosense Webster, INC. | $23.72 | 2023 | Na |
| Janssen Pharmaceuticals, INC | $18.88 | 2022 | |
| Cook Medical LLC | $16.18 | 2022 | |
| Biotronik INC. | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brinder Kanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.